UC San Diego

BackgroundIntravenous self-administration (IVSA) of opioids by rats has been shown frequently to exhibit no sex differences, in many cases a higher intake of females, and only rarely higher rates in males. A diversity of methodological parameters (opioid identity, training doses, rat strain, session duration) makes it difficult to identify consistent contributions to these outcomes.ObjectiveTo determine if Heterogeneous Stock (HS) rats derived from 8 founder strains differ by sex in the IVSA of opioids.MethodsMale and female Heterogeneous Stock (N = 7–8 per sex) rats were permitted to self-administer heroin (20 µg/kg/infusion) in 2 h sessions under a Fixed Ratio 1 schedule of reinforcement. After acquisition, animals completed sessions in which different infusion doses of heroin (0, 15, 30, 60, 120 µg/kg/infusion), oxycodone (0, 30, 60, 150, 300 µg/kg/infusion) and fentanyl (0, 0.625, 1.25, 2.5, 5.0 µg/kg/infusion) were assessed. Next, animals were evaluated on doses of heroin (15, 30, 60, 120 µg/kg/infusion), oxycodone (30, 60, 150, 300 µg/kg/infusion) and fentanyl (0.625, 1.25, 2.5, 5.0 µg/kg/infusion) under a Progressive Ratio schedule. Anti-nociceptive effects of heroin (0.56–2.4 mg/kg, s.c.) were examined with a warm water tail-withdrawal assay.ResultsFemale HS rats consistently self-administered more infusions of opioids, including heroin during acquisition, all three opioids during FR-1 dose substitution and of oxycodone and fentanyl in the PR procedure. Male rats were moderately more sensitive to the anti-nociceptive effects of heroin.ConclusionsFemale rats drawn at random from a genetically diverse population self-administer opioids at higher rates than their male counterparts.